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Tightjunctions(TJs)typicallyrepresentthemostapicalcontactsinepithelialandendothelialcelllayerswheretheyplayanessential
roleintheseparationofextracellularorluminalspacesfromunderlyingtissuesinthebody.Dependingontheproteincomposition,
TJsdeﬁnethebarriercharacteristicsandinadditionmaintaincellpolarity.Twomajorfamiliesofintegralmembraneproteinsform
the typical TJ strand network, the tight junction-associated MARVEL protein (TAMP) family members occludin, tricellulin, and
MarvelD3 as well as a speciﬁc set of claudins. Occludin was the ﬁrst identiﬁed member of these tetraspanins and is now widely
acceptedasaregulatorofTJassemblyandfunction.Therefore,occludinitselfhastobetightlyregulated.Phosphorylationofocclu-
dinappearstobeofcentralimportanceinthiscontext.Herewewanttosummarizecurrentknowledgeonthekinasesandphospha-
tases directly modifying occludin, and their role in the regulation of TJ structure, function, and dynamics.
1.Introduction
Tight junctions (TJs) represent the uppermost cell-cell-con-
tact sites at the lateral membrane interface of endothelial or
epithelial cells. In freeze-fracture electron microscopy, TJs
appear as a set of branched anastomosing strands of protein
particles which bring opposing cell membranes into close
contacts [1]. It is still a matter of debate whether and how
plasma membranes are involved in contact formation at
these “kissing points” separating the extracellular space and
the inner milieu. As belt-like strands around the cells, TJs
sealtheparacellularcleftsbetweenneighboringcellsandthus
provide a barrier which protects the organism against pas-
sageoftoxinsormicroorganismsandregulatestheparacellu-
lar passage of ions, water, and other solutes [2]. The speciﬁc
protein composition of tight junctional complexes deﬁnes
the barrier characteristics and generates leaky or tight cell
layers. The permeability of epithelial cell layers can be evalu-
atedattwodiﬀerentlevels.Thetransepithelialelectricalresis-
tance (TER) representing the contribution of both the para-
cellular resistance (R para, reﬂecting the resistance of the TJs)
and the transcellular resistance (R trans, reﬂecting the resis-
tance of the apical and basolateral membranes) can be
measuredbytwo-pathimpedancespectroscopytodetermine
the permeation of ions [3]. At the second level, the ﬂux of
tracers of diﬀerent sizes evaluates the TJ pore size. In addi-
tion, TJs act as a fence that maintains cell polarity, by block-
ingthefreediﬀusionofproteinsandlipidsbetweentheapical
and basolateral domains of the plasma membrane [4].
In association with a set of intracellular scaﬀolding pro-
teins including the PDZ-domain-containing zonula occlu-
dens proteins (ZO-1, ZO-2, and ZO-3), the MAGI proteins
(MAGI1, MAGI2, and MAGI3), PAR-3 and -6, MUPP, and
PATJ (reviewed in [5]), TJs are connected with the cytoskele-
ton and form a regulatory platform mediating responses to
intracellular and extracellular signals. The domain composi-
tion of the ZO-proteins containing three N-terminal PDZ
domains, whicharefollowed bya Src-homology 3 (SH3) and
aguanylatekinase(GUK)domainclassiﬁesthemasmembers
of the membrane-associated guanylate kinase homologues
(MAGUK) protein family. ZO-1 and ZO-2 in addition are
characterized by a C-terminal extension including an acidic
module and a proline-rich region, which is involved in the
association of TJs with the actin cytoskeleton. Despite their
similar domain structure, the ZO-proteins have distinct
activitiesandonlypartiallycompensateeachother’sfunction2 Journal of Biomedicine and Biotechnology
[6, 7]. Especially, ZO-3 requires preassociation of ZO-1 and/
orZO-2andcannotbindtojunctionalareasbyitself[8].The
modular composition of these PDZ domain-containing pro-
teinsallowsthemtomediatemultipleinteractionswithother
factors to assemble cytoskeletal and signaling molecules
around the integral tight junctional proteins. Other proteins
such as cingulin and symplekin have been shown to associate
with the cytoplasmic tight junctional plaque acting either as
scaﬀolding or modulatory proteins (for review see [9]).
Theidentiﬁcationofoccludinastheﬁrsttetraspaninpro-
tein of the TJ nearly twenty years ago by Furuse et al. [10]
started a new area in tight-junction research. Now in addi-
tion to occludin, at least 24 claudins are known which spec-
ify the barrier properties of epithelia in diﬀerent organs
and tissues. Like occludin, claudins are integrated into the
membrane by four transmembrane domains; however, they
only have short cytosolic N- and C-terminal sequences re-
sulting in an apparent molecular mass of about 23kDa. Des-
pite their common tetraspanin structure and colocalization,
occludin and claudins show no sequence similarity and
thusapparentlyrepresentseparatephylogeneticallyunrelated
protein families. The tissue-speciﬁc expression pattern of the
claudins meanwhile has been analyzed in much detail, and
many claudins have been studied with respect to their func-
tionalpropertiesassealingorpore-formingproteins.Knock-
outofdistinctclaudinsprovidedfurtherinsightintothephy-
siologicalroleofthediﬀerentclaudins.Moredetailsonstruc-
tural and functional aspects of claudins are provided by
recent comprehensive reviews [11–14].
Meanwhile, tricellulin (MarvelD2) and MarvelD3 have
beencharacterizedasfurtherTJ-speciﬁctetraspaninproteins
which together with occludin form the TJ-associated marvel
proteins (TAMPs), which share a conserved MARVEL (MAL
and related proteins for vesicle traﬃcking and membrane
link) domain of four transmembrane domains linked by two
extracellular (ECL) and one intracellular loop (ICL) [15]. As
indicated by its name, tricellulin preferentially is located at
tricellular TJs where it forms a barrier to macromolecules
[16]. In addition, tricellulin has an essential role in TJ for-
mation. Knockdown of tricellulin aﬀects tricellular TJs but
in addition also results in disorganized bicellular TJ strand
continuity [17]. MarvelD3, a recently discovered third mem-
ber of the TAMPs, is preferentially localized in bicellular TJs
and is not essential for TJ formation [18, 19]. Obviously, the
three TAMPs have overlapping functions that cannot be
completely compensated by the other members [18]. Dis-
crepant results have been reported in the literature whether
TAMP proteins may form heteromeric complexes [18, 20].
In addition to the tetraspanin proteins, diﬀerent mem-
bers of the immunoglobulin superfamily of adhesion recep-
tors have been localized to TJs including the junctional adhe-
sion molecules (JAMs) (reviewed in [21, 22]), coxsackie ade-
novirus receptor (CAR) [23] and ESAM [24]. These single
transmembrane domain proteins are assumed to be involved
in early steps of contact formation during TJ assembly and in
TJ modulation. They are not able to reconstitute TJ strands
by themselves and are assumed to be associated laterally to
the TJs (for review see [4]).
2. Occludin in Tight Junctions
Humanoccludinisencodedonchromosome5q13.1asapro-
tein of 522 amino acids [25]. At least, four splice variants
havebeenidentiﬁedatthemRNAlevelwhichappeartoexhi-
bit altered subcellular distribution and are in part generated
by alternative promoter usage [26]. Occludin is expressed in
epithelial cells but is not detectable in ﬁbroblasts. Antibodies
against occludin detect a set of bands around 60kDa, which
either are products of alternative splicing or represent pro-
teins carrying posttranslational modiﬁcations. Most studies
on occludin were performed with the 522 amino acid pro-
tein. Thus, in the following when we use the term occludin,
werefertothe522aminoacidproteinoritshomologinother
organisms.
After the initial identiﬁcation of occludin numerous
studies were performed to analyze its expression and func-
tion in more detail. Overexpression of occludin in insect Sf9
cells resulted in the formation of intracellular multilamellar
bodies suggesting that occludin is in principle able to form
tight junction strands [27]. However, when occludin was ex-
pressed in epithelial MDCK cells, it was integrated into TJs
and induced an increase in TER but unexpectedly also in-
creased paracellular ﬂux [28, 29]. Treatment of cells with
peptides from the extracellular loops of occludin impaired
membrane localization and barrier function of occludin
although discrepant results were observed for ECL1- and
ECL2-derived peptides (for review see [30]). Further studies
revealed that in addition to the ECLs at least one occludin
transmembranedomainisinvolvedintheregulationofpara-
cellular permeability [31].
Unexpectedly, occludin knock-out mice were viable and
showednormalTJstrandformationsuggestingthatoccludin
is not essential for barrier formation. However, the animals
displayed other signs of pathological disorders such as
growth retardation, testicular atrophy and male infertility,
dysfunction of the salivary gland, calciﬁcation in the brain,
thinning of the compact bone, and gastric inﬂammation and
mucus cell hyperplasia [32, 33]. This ﬁnally led to the iden-
tiﬁcation of the ﬁrst claudins 1 and 2 [34]a sm a j o rc o n s t i -
tuents of TJs which are able to reconstitute TJ strands and
to recruit occludin to the TJs [35]. In occludin knockdown
MDCK cells, TJs were formed and revealed an apparently
normal morphology. Interestingly, the expression of distinct
claudins was changed, and the ability to extrude apoptotic
cells from the monolayer was reduced [36]. Moreover,
knockdown of occludin results in an enhanced localization
of tricellulin into bicellular TJs suggesting that occludin
is involved in the translocation of tricellulin to tricellular
TJs [37]. However, diﬀerent results were reported probably
depending on the cell type used in the studies [37, 38]. Hete-
romeric complex formation between occludin and tricellulin
may contribute to this mechanism [20]. Recently, the cyto-
plasmic domain of LSR (lipolysis-stimulated lipoprotein
receptor) has been characterized to deﬁne tricellular contacts
for the recruitment of tricellulin [39].
Together with the observations that TJs can be formed
in the absence of occludin, there is compelling evidence that
occludin, has a regulatory role in TJs in forming a platformJournal of Biomedicine and Biotechnology 3
for signaling processes. Multiple stimuli have been identiﬁed
which modulate TJ structure and function including growth
factors (such as EGF, TGFβ, HGF, PLGF-1, and VEGF), oxi-
dativestressandthiols,inﬂammationandcytokinesandhor-
mones (for review see [30, 40–43]).
Two recent studies clearly have indicated that cytokine-
induced changes in TJ structure and function require oc-
cludin in a pathway including myosin light chain kinase
(MLCK)-dependentmyosinlightchain(MLC)phosphoryla-
tion triggering perijunctional actomyosin ring condensation
and caveolin-1-mediated occludin internalization [38, 44].
Knockdown of occludin attenuated TJ remodeling in MDCK
II cellsinduced by combined treatment with IFNγ and TNFα
or by latrunculin A treatment, an eﬀect not seen when tri-
cellulin was knocked down [38]. The inhibition of occludin
endocytosis by inhibitors or depletion of caveolin-1 in cells
or mice prevented TNFα-induced barrier changes [38, 44].
Taken together, this clearly indicates that occludin plays an
essential role in the regulation of cytokine-induced barrier
properties.
Moreover, the tight junctional plaque attracts numerous
signalingmoleculesinvolvedinRhoAandRac1signaling(for
review see [45]) including p114RhoGEF [46] or GEF-H1
[47]. The tight junctional plaque itself includes proteins
with NACos (nucleus and adhesion complexes) function,
which translocate between junctional complexes and the
nucleus where they modulate gene transcription. Both ZO-1
and ZO-2, symplekin, huASH1, and ZONAB represent tight
junctional proteins with NACos activities (for review see [48,
49]). Posttranslational modiﬁcations, especially phosphory-
lation/dephosphorylation are critically involved in the regu-
lation of such signaling processes. Based on the assumption
that occludin plays a central role in the regulation of TJ as-
sembly and function, phosphorylation of occludin and its
consequences have attracted much attention during recent
years. Here, we want to focus on kinases and phosphatases,
which have been shown to directly target and modify occlu-
din and thus aﬀect its function in TJs. This does not exclude
that these kinases or phosphatase do not in addition target
other integral or peripheral TJ components.
3. Tyrosine Phosphorylation of Occludin by
Src-FamilyKinases(SFKs) and FAK
The Src family of kinases (SFKs) includes 9 members of non-
receptor tyrosine kinases: c-Src, Lyn, Fyn, Lck, Hck, Fgr, Blk,
Yrk, and Yes. c-Src is the most prominent and best studied
SFK member and is frequently activated during processes
deregulated in cancer such as cell proliferation, migration,
survival, and angiogenesis. SFKs are characterized by a
highly conserved domain structure composed of four Src-
homology(SH)domainsandbyfattyacidmodiﬁcationofits
N-teminus driving translocation to the plasma membrane.
c-Src is inactivated by a combined mechanism where the
phosphorylation of aC-terminal tyrosine residue close tothe
tyrosine kinase domain (SH1) induces its interaction with
the internal SH2 phospho-tyrosine-binding domain, and by
the interaction of a proline-rich motif in the linker region
between SH2 and SH1 with the SH3 domain (for review see
[50]).
Early studies suggested that tyrosine kinases of the Src
family are critically involved in TJ regulation. Treatment of
epithelial MDCK II with hydrogen peroxide disrupts TJs
with a subsequent drop in TER, which was reversed by ex-
change of medium or was inhibited by treatment with cata-
lase and heavy metal chelator TPEN. Tyrosine kinase inhi-
bitors PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)-pyra-
zolo[3,4-d]pyrimidine) and genistein (49,5,7-trihydroxyiso-
ﬂavone) blocked reassembly of TJ after hydrogen peroxide
treatment [51]. Similarly, in Ras-transformed MDCK cells
with absent occludin-, claudin-1-, and ZO-1-staining at cell-
cell contacts, treatment with the MEK1 inhibitor PD98059
induced reassembly of tight junctions and increased tyrosine
phosphorylation of occludin and ZO-1 [52]. These observa-
tions suggested that SFKs are involved in TJ assembly. As a
candidate kinase responsible for these eﬀects, c-Yes was iden-
tiﬁed using a peptide from the coiled-coil domain in the C-
terminal domain of occludin [53]. Moreover, depletion of
Ca2+ from the cell culture medium induced a rapid dephos-
phorylation of tyrosine residues in occludin in MDCK II
cells. Readdition of Ca2+ reverted this eﬀect, which was inhi-
bited in the presence of the c-Yes inhibitor CGP77675. In-
deed, c-Yes colocalizes with occludin at tight junctional cell-
cell contacts, and an interaction has been recently conﬁrmed
at the blood-testis barrier (BTB) as shown by coimmunopre-
cipitation experiments in sertoli cells isolated from Sprague-
Dawley rats. The inhibition of c-Yes with SU6656 (inhibitor
for Src family kinases, with an IC50 of 20nM for c-Yes but
280nM, 170nM and 130nM for c-Src, Fyn and Lyn, resp.)
results in a redistribution of occludin and N-cadherin from
the cell surface to the cytosol and a breakdown in TER [54].
However, direct phosphorylation of occludin by c-Yes was
not shown and the residues targeted by c-Yes were not iden-
tiﬁed. In contrast to the barrier promoting eﬀects of c-Yes,
activation and membrane translocation of c-Src in response
to oxidative stress weakens the barrier properties of Caco-
2 cells and resulted in redistribution of occludin and ZO-1
fromintercellularjunctionstothecytosol.Inhibitionofc-Src
oroverexpressionofakinase-deadc-SrcK297Rproteinabro-
gated these eﬀects. Interestingly, c-Src in contrast to c-Yes
delayed relocalization of occludin to TJs after readdition of
Ca2+ in Ca2+-switch experiments [55]. The diﬀerent eﬀects
induced by c-Yes and c-Src cannot be explained by the dif-
ferent cell types since c-Src showed a similar mechanism of
TJ regulation in MDCK cells.
In vitro studies conﬁrmed direct binding of c-Src to a
GST-occludin C-terminal domain fusion protein and phos-
phorylation by c-Src-diminished binding of the occludin
C-terminus to ZO-proteins from cell lysates but did not
aﬀect binding to actin ﬁlaments [56]. Tyrosine residues
Y398/Y402 in a highly conserved YETDYTT motif in human
occludin were identiﬁed as the c-Src phosphosites (see
Figure 1). Mutation of these residues to alanine abolished
c-Src-mediated phosphorylation of occludin in in vitro
phosphorylation assays. In Ca2+-switch experiments, a phos-
phomimetic occludin-Y398D/Y402D construct was impai-
red in binding to ZO-1 and reassembled into TJs with a4 Journal of Biomedicine and Biotechnology
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Figure 1: Schematic presentation of occludin and localization of the amino acid residues targeted by speciﬁc kinases.
signiﬁcant delay compared to wild-type occludin or occlu-
din Y398A/A402A. In agreement with this, expression of
occludin Y398D/Y402D sensitized MDCK cells for hydrogen
peroxide-induced barrier disruption [57]. A recent study has
identiﬁed tyrosine 473 as another putative SFK phospho-
rylation site using a phosphorylation site-speciﬁc antibody.
Phosphorylation of Y473 in the occludin C-terminal domain
is a prerequisite for its interaction with the cSH2-domain of
the p85α regulatory subunit of PI3K (also see below). Bind-
ing was abolished in cells expressing Y473F-mutated occlu-
din.Phosphorylatedoccludin thusrecruitsactivePI3Ktothe
leading edges of migrating cells as shown in wound healing
assays thereby regulating Rac1 activation and actin dynamics
[58]. A similar translocation of PI3K to junctions and bind-
ing to occludin was also observed in response to oxidative
stress [59].
Focal adhesion kinase (FAK) represents a highly con-
served cytosolic protein tyrosine kinase with essential roles
during embryonic development and in the pathogenesis of
cancer and cardiovascular disease. Structural analyses revea-
led an N-terminal FERM (band4.1, ezrin, radixin, and
moesin homology), a central catalytic and a C-terminal FAT
(focal adhesion targeting) domain composition of FAK. The
latter domains are separated by an unstructured proline-rich
sequence. FAK plays a central role in the regulation of cell
migration, cytoskeleton, and cell adhesion especially by sig-
nals from the extracellular matrix in mechanotransduction.
Intramolecular binding of the FERM domain to the cata-
lytic domain blocks access to the catalytic cleft and activation
of FAK by autophosphorylation of Y397, which in its phos-
phorylated state, provides a binding site for SKF-members
(for review see [60, 61]).
The administration of acetaldehyde to human colonic
biopsies activated c-Src and FAK and reduced protein
tyrosine phosphatase activity, thereby increasing the tyrosine
phosphorylationofoccludin,E-cadherin,andβ-catenincon-
comitant with a redistribution of occludin, ZO-1, E-cad-
herin, and β-catenin from the detergent-insoluble to the det-
ergent-soluble fraction and a loss of occludin from intercel-
lular junctions. Pretreatment with EGF or L-glutamine pre-
vented these eﬀects [62]. In sertoli cells, colocalization and
interaction of FAK with occludin and ZO-1 was observed.
A siRNA-mediated knockdown of FAK resulted in the dis-
ruption of barrier function (decrease in TER). In these cells,
occludin staining at the plasmamembrane was reduced, as
well as its interaction with ZO-1. Moreover, diminished
phosphorylation of occludin on tyrosine and serine but not
on threonine residues was observed [63]. It is currently not
known whether a direct, FAK-mediated phosphorylation of
occludin, or a secondary mechanism induced by FAK-dep-
endent modulation of the cytoskeleton is responsible for
these eﬀects.
4. Phosphorylation of Occludin by
Rho Kinase(RhoK)
Rho kinases (RhoK) are serine/threonine kinases that act
downstream of the small GTPase Rho with multiple func-
tionsintheregulationofthecytoskeleton,polarityandmoti-
lity of cells [64]. Early studies indicated that Rho signaling is
involvedintheregulationofTJs.TheinhibitionofRhobyC3
transferase-mediated ADP ribosylation resulted in reduced
localization of ZO-1 and occludin at cell junctions. Mu-
tant Rho-GTPase expression (dominant-active Rho-V14 or
dominant-negative Rho-N19) altered the levels of phospho-
serine/phosphothreonine occludin isoforms [65, 66]. In
ECV304 cells, LPA was found to increase the paracellular
permeability of the tracer horseradish peroxidase, whereasJournal of Biomedicine and Biotechnology 5
a dominant-negative mutant of RhoA (RhoA T19N) or a
speciﬁc inhibitor of the downstream RhoK (p160ROCK),
Y-27632, prevented these eﬀects. Interestingly, histamine
treatment also increases occludin phosphorylation, however,
independentofRhoandRhoK[67].Furthermore,inhibition
of Rho was shown to prevent migration of monocytes
through the blood brain barrier (BBB). Dominant-negative
RhoK and RhoK inhibitors reduced monocyte transmigra-
tion and occludin phosphorylation [68]. This suggested, that
RhoK directly phosphorylates occludin and other tight junc-
tional proteins. A recent study has identiﬁed T382 and S507
in mouse occludin and T207 in claudin-5 as speciﬁc target
sites of RhoK. The activation of RhoK by LPA induced phos-
phorylation of these sites and decreases TER in brain micro-
vascular endothelial cells (BMVECs), whereas a RhoK inhi-
bitor (Y27632) prevented the decrease in TER although the
phosphorylation of occludin was only partially inhibited
[69].
5.MAP Kinases (MAPKs) and
Occludin Phosphorylation
Mitogen-activatedproteinkinases(MAPkinases)representa
family of small Ser/Thr kinases (ERK, p38/MAPK, and JNK),
which are activated by a cascade of kinases (MAPK kinase,
MEK;MAPKKkinase)inresponsetodiﬀerentgrowth,stress,
and inﬂammatory stimuli. Deregulated activation is freque-
ntly detected in disease including various cancers, inﬂamma-
tory, and neuronal diseases [70].
Treatment of MDCK cells with the Na+,K +-ATPase
inhibitor ouabain lead to MAPK activation and redistribu-
tion of occludin, ZO-1, and other apical junctional complex
proteins including E-cadherin from cell-cell contacts and
to a concomitant drop in TER [71]. Stable transfection of
constitutive active MEK-1 reduced tyrosine phosphorylation
of occludin and weakened the barrier, whereas a dominant-
negative MEK-1 elevated TER and tyrosine phosphorylation
in THCE (SV40-immortalized human corneal epithelial)
cells [72]. Similarly, ERK activation with a subsequent break-
down of TJs was observed in epithelial cells expressing con-
stitutively active Ras or Raf-1 [52, 73]. The administration of
H2O2 induces barrier breakdown, as measured by increasing
inulin permeability, decreasing TER, redistribution of occlu-
din and ZO-1 from TJs to intracellular compartments, and
increasing threonine phosphorylation of occludin in Caco-
2 cells. However, in this study, the activation of the MAPK
by EGF restored the barrier defects, whereas the inhibition of
MAPKsignalingpathwaywiththeMEKinhibitors(PD98059
andU0126)abolishedtheprotectiveeﬀectofEGF.Moreover,
the authors showed that ERK1 colocalizes with occludin
at the TJ and directly interacts with the occludin C-termi-
nal domain in pull-down assays [74]. An explanation for
the discrepant results in respect to the role of MAPK is
given by a recent study which showed that EGF potenti-
ated H2O2-induced tight junction disruption in under-dif-
ferentiated Caco-2 cell monolayers but prevented H2O2-in-
duced disruption of tight junctions in diﬀerentiated cells.
ThisappearstobeduetoadiﬀerentialdistributionofERKin
underdiﬀerentiated and diﬀerentiated cells. Moreover, EGF
diﬀerentially modulates the association of PP2A and PKCζ
with occludin in these cells [75]. In addition to ERK, an in-
teraction of p38/MAPK and PI3K with occludin after treat-
ment with LPS was shown by coimmunoprecipitation exper-
iments[76].ERKbutnotp38/MAPKorJNKactivationisin-
volved in the EGF-mediated attenuation of TJ disruption in
acetaldehyde-treated cells [77]. In contrast, TJ disruption in
response to osmotic stress is mediated by JNK2 [78]. The
amino acids phosphorylated by MAPK have not been iden-
tiﬁed so far.
6. Direct Phosphorylation of Occludin by PKCs
Protein kinases C (PKCs) represent a family of serine/thre-
onine kinases consisting of nine isoforms that can be classi-
ﬁed into three subgroups: the conventional PKCs (cPKCs:
PKCα, βI/βII,a n dγ), the novel PKCs (nPKCs: PKCδ, ε,
η,a n dθ), and the atypical PKCs (aPKCs: PKCζ and ι/λ).
The structural and functional features of these kinases are
reviewed in [79].
An early investigation using the pan-PKC inhibitor cal-
phostin C resulted in a delayed assembly of TJs in Ca2+-
switch experiments but did not aﬀect sorting of E-cadherin
or of desmoplakin suggesting that PKC is speciﬁcally invol-
ved in the regulation of TJs. A phosphorylated 65kDa pro-
tein detected in these studies was speculated to represent
occludin [80]. Numerous further studies using diﬀerent PKC
inhibitors or activators have provided clear evidence that
PKC is involved in the regulation of TJs although data appa-
rentlywerecontradictory.Diﬀerentcellularsystemsandcon-
ditions, the presence of more than one PKC isoform in a cell,
and their speciﬁc and probably overlapping functions lead
to complex and sometimes diﬃcult to interpret observations
also with respect to PKC-dependent occludin phosphoryla-
tion.Therefore,itappearstobehelpfultoidentifythespeciﬁc
amino acid residues in occludin, which are phosphorylated
by speciﬁc PKCs and to mutate them to ﬁnally generate oc-
cludin variants that no longer can be phosphorylated or that
mimic constitutive phosphorylation.
In this respect, in a study using MDCK cells cultivated in
low Ca2+-medium to disrupt TJs, treatment of the cells with
the PKC activators PMA or diC8 induced redistribution of
occludin to cell-cell contacts and to the triton X-100 insol-
uble fraction. These eﬀects were abolished by the pan-PKC
inhibitor GF-109203X. However, the cPKC inhibitor G¨ o6976
did not inhibit reassembly of occludin into TJs, whereas the
nPKCinhibitorrottlerinwasactive.Fromtheseobservations,
it was concluded that cPKCs and nPKCs antagonistically reg-
ulate assembly of TJs [81, 82]. In vitro phosphorylation and
subsequent mass spectrometric analysis identiﬁed Ser338 as
a potential cPKC phosphorylation site [81].
In Caco-2 and MDCK cells, occludin interacts with
PKCη. Overexpression of wild-type PKCη or constitutive ac-
tive PKCA161E increases TER, reduces inulin permeability,
and increases occludin staining at the membrane, sugges-
ting augmented barrier properties. These eﬀects could be
blocked by shRNA-induced knockdown of PKCη or applica-
tionofPKCηpseudosubstrate.Mutationalanalysesidentiﬁed
three residues (T403, T404, and T438) in the C-terminal6 Journal of Biomedicine and Biotechnology
domain of occludin as target residues of PKCη with amino
acids T403 and T404 veriﬁed by mass spectrometry. Since a
single T404A mutation completely abolishes PKCη-depen-
dent phosphorylation, it was speculated that phosphoryla-
tion of T404 may be a prerequisite for the subsequent phos-
phorylation of T403. Moreover, occludin-T403D/T404D was
localizedpreferentiallyatthejunctionalmembranes,whereas
occludin-T403A/T404A was detected in the intracellular
compartment. Interestingly, expression of the occludin-
T403D/T404D construct enhanced ZO-1 junctional localiza-
tion, whereas the alanine-mutated occludin had the opposite
eﬀect [83].
Atypical PKCζ also binds to the occludin C-terminus
and phosphorylates it on threonine residues. In addition to
amino acids T403 and T404, T424 and T438 were identiﬁed
as sites phosphorylated by PKCζ (summarized in Table 1).
Mutation of T424 and T438 to alanine results in a misloca-
lizationofoccludininintracellularcompartmentsanddelays
its assembly into TJs after Ca2+-induced reassembly of TJs.
To speciﬁcally address the physiological role of PKCζ, kinase
activity was inhibited by a pseudosubstrate peptide or by
siRNA-mediated knockdown. In MDCK and Caco-2 cells
this results in a decreased barrier function as determined by
a reduction in TER and an increase in inulin permeability,
reduced phosphorylation of occludin, dissociation of oc-
cludin from the detergent insoluble fraction, redistribution
of occludin to the cytosol and a delay of Ca2+-induced TJ
reassembly [84]. It is not clear whether these eﬀects are spe-
ciﬁc for phosphorylation of T424 and T434 or in addi-
tion depend on phosphorylation of T404 and T403 by PKCζ.
Moreover,aPKCwithinthepolaritycomplexhasbeenshown
to interact with occludin in coimmunoprecipitation experi-
ments [58]. Whether aPKC phosphorylates occludin in this
context has to be determined.
7 .P h o s p h o ryl a ti o no fO c c l u d i nb y
CK1 andCK2
CK1andCK2(formerlyknownascaseinkinase1and2)rep-
resentubiquitouslyexpressedserine/threoninekinasesdetec-
table in all eukaryotic organisms. The mammalian CK1 fam-
ilyincludessevenisoforms(α,β,δ,ε,γ1,γ2,andγ3)encoded
by distinct genes which can be post-transcriptionally pro-
cessed into a number of splice variants. CK1 is a monomeric
kinase which has been shown to be involved in the regulation
of diverse cellular processes including Wnt signaling, cir-
cadian rhythms, and cytoskeleton maintenance and itself is
regulated by posttranslational modiﬁcations (for review see
[85]). CK1 directly binds and phosphorylates the occludin
C-terminus [86]. In addition, in vitro kinase experiments
using a GST-occludin N-terminal fusion protein as a sub-
strate revealed phosphorylation of the occludin N-terminus
[87].TheaminoacidsmodiﬁedbyCK1phosphorylationand
the physiological eﬀects are currently unknown.
CK2 is a tetrameric protein with two enzymatic α-sub-
units (α, α ) and two regulatory β-subunits. Multiple cellu-
lar processes including cell proliferation, apoptosis, gene ex-
pression,andthecircadianrhythmareregulatedbyCK2.The
constitutive active protein appears to be regulated by its
subcellular distribution in response to diﬀerent signals (for
review see [88,89]).FirstevidenceforaCK2-mediatedphos-
phorylation of occludin was provided by in vitro phosphory-
lation experiments with the Xenopus laevis occludin C-ter-
minal domain [90]. Later CK2 was puriﬁed from porcine
brain extracts conﬁrming an interaction of the kinase with
occludin [91]. CK2 phosphorylates T375 and S379, and the
corresponding amino acids T403 and S407 in Xenopus and
mouseoccludin,respectively,[90,91].Mutationoftheseresi-
dues to alanine or aspartate abolishes or at least diminishes
phosphorylation of occludin. Our own studies have recently
identiﬁed T400 as a third amino acid residue with the
cluster T400-X-X-X-T404-X-X-X-S408 in human occludin,
which is phosphorylated by CK2. Only mutation of all three
residues to alanine resulted in a complete loss of occludin
phosphorylation in in vitro phosphorylation assays. Interest-
ingly, introduction of a phospho-mimetic S408E mutation
into the occludin C-terminus increased CK2-dependent
phosphorylation in comparison to the corresponding triple
alanine mutant suggesting that prephosphorylation of S408
enhances phosphorylation of T404 and T400 [87].
Until recently, the physiological consequences of occlu-
din phosphorylation by CK2 were unknown. Studies by
Raleigh et al. [92] provided interesting ﬁrst insight into the
sophisticated role of CK2 in the assembly of TJs. Treatment
of Caco-2 cellswith diﬀerent CK2 inhibitors or siRNA-medi-
ated knockdown of CK2 resulted in enhanced barrier func-
tion as evaluated by increased TER values, reduced paracel-
lular Na+-ﬂux. In line with this, the inhibition of CK2 in-
creased the amount of tight junctional occludin. Interest-
ingly, knockdown of occludin prevented elevation of TER by
the inhibition of CK2 activity, suggesting that CK2-depen-
dentregulationofTJbarrierfunctionisoccludin-dependent.
Expression of EGFP-tagged occludin constructs in Caco-2
cells with knocked down endogenous occludin was used to
analyze the mobile fraction of the diﬀerent occludin con-
structs in FRAP (ﬂuorescencerecovery after photobleaching)
experiments. CK2 inhibition reduced the mobile fraction of
occludin.Moreover,themobilefractionsofoccludin-T404A/
S408A and -S408A were signiﬁcantly reduced compared to
wildtype occludin and occludin-T404D/S408D, -T404A, and
-S408D. In addition, Raleigh et al. reported that occludin-
S408D C-terminal tail binds more endogenous occludin,
whereas occludin-S408A associates more eﬃciently with
claudin-1 and -2, and this appears to be mediated by ZO-1
acting as a scaﬀold. However, knockdown of ZO-1 or clau-
din-2 eliminated TER and Na+-ﬂux responses to CK2 inhi-
bition, indicating an essential role of ZO-1 and claudin-2
in the occludin-mediated response to CK2 inhibition. Fin-
ally, the inhibition of CK2 was observed to reverse IL-13-in-
duced, claudin-2-dependent barrier disruption. These data
were summarized in a model postulating that phosphory-
lation of S408 in occludin acts as a switch in the CK2-medi-
ated regulation of TJ structure and paracellular permeability
in determining whether occludin forms mobile homodimers
orheterotypic complexeswith ZO-1,claudin-1, andclaudin-
2 involved in the control of the TJ paracellular leak
pathway [92]. Our own studies using MDCK cells stably
transfected with FLAG-tagged wildtype occludin or theJournal of Biomedicine and Biotechnology 7
Table 1: Summary of known occludin phosphorylation sites in the context of the kinases or stimuli that induce phosphorylation at these
sites and the eﬀects on TJ function generated by induced or inhibited phosphorylation. Green label: kinase overexpression, stimulation
or phospho-mimetic occludin variant; red label: kinase knockdown, inhibition or occludin variant that cannot be phosphorylated at the
speciﬁed amino acid site.
c-Src
Y398/Y402
overexpression/
stimulation:
TER ↓
junctional Occ ↓
Caco-2
MDCK
Rat-1
[55–57]
Y398D/Y402D-
mutation/
phosphorylation:
TJ-assembly ↓
inulin permeability ↑
junctional Occ ↓
interaction of Occ with ZO-1, 
inhibition/
knockdown:
TER ↑
-2 and -3 ↓
TJ-assembly ↑
Y398A/Y402A-
mutation:
junctional Occ ↑
TJ-assembly →
inulin permeability →
c-Src
Y473 (mouse)
Y473D-mutation:
interaction of Occ with PI3K ↑
attenuated wound healing 
and migration
increased wound healing 
and migration MDCK
A431
[58]
[69]
Y473F-mutation:
ROCK
(T382)/S507
(mouse)
overexpression/
stimulation:
TER ↓
COS-7
inhibition/
knockdown:
TER ↑
cPKC
S338 (mouse)
overexpression/
stimulation:
insoluble pool of Occ ↑ (?)
junctional Occ ↑ (?)
MDCK [81, 82]
[82, 83]
nPKCη
T403/T404
(438)
overexpression/
stimulation junctional Occ ↑
MDCK
Caco-2
T403D/T404D-
mutation
inhibition/
knockdown:
junctional Occ ↓
assembly ↓
T403A/T404A
-mutation
junctional Occ ↓
junctional ZO-1 ↓
TER ↓
inulin permeability ↑
inulin permeability ↓
interaction of Occ with PI3K ↓
TER ↑
inulin permeability ↓
junctional Occ ↑
TER ↑
inulin permeability ↓
inulin permeability ↑
TER ↓
kinase/site Effect Cell type Reference8 Journal of Biomedicine and Biotechnology
Table 1: Continued.
aPKCζ
(T403/T404)
inhibition/
knockdown:
TER ↓
permeability ↑
Assembly ↓
junctional Occ ↓
Rat-1
MDCK II
Caco-2
T424/T438
kinase/site Effect Cell type Reference
T424A- or
T438A-mutation
junctional Occ ↓
junctional Occ ↓
Assembly ↓
CK2
(T400)/T404/S408
S408D-mutation
Occ exchange →
Occ dimerization ↑
Occ dimerization ↑
interaction of occludin with
ZO-1,Cld-1 and Cld-2 ↓
interaction of occludin with
ZO-1, Cld-1 and Cld-2 ↑
Caco-2
MDCK
T84
inhibition/
knockdown:
TER ↑
Na2+ -ﬂux ↓
ZO-1, Cld-1, Cld-2 exchange ↑
ZO-1, Cld-1, Cld-2 exchange ↑
T404A/S408A
Occ exchange ↓
Occ dimerization ↓
interaction of occludin with
ZO-1, Cld-1 and Cld-2 ↑
interaction of Occ with ZO-1 ↓
interaction of Occ with Itch ↑
interaction of Occ with Itch ↓
ZO-1, Cld-1, Cld-2 exchange ↑
Occ exchange ↓
S408A
junctional Occ ↑
T404A Occ exchange →
VEGF S490
overexpression/
stimulation
TER ↓
permeability ↑
BREC S490D-mutation Occ degradation ↑
Occ degradation ↓
S490A-mutation:
junctional Occ ↑
TER ↑
permeability ↓
[100, 101]
[87, 90–92]
[84]
triple-site mutated occludin-T400A/T404A/S408A or -T40-
0E/T404E/S408E constructs, however, showed that the phos-
phomimeticconstructincreasedTERandlesseﬃcientlybind
to ZO-2 (D¨ orfel et al., unpublished results). Nevertheless, it
can be concluded that the amino acid sequence motif 400–
408 represents a hot spot for Ser/Thr kinases including PKCs
and CK2, which is critically involved in the regulation of TJ
structure and function (see Figure 1). Future studies have
to unravel whether phosphorylation of amino acids within
this cluster may aﬀect the formation of disulﬁde bonds and
dimerization of occludin [93] especially under conditions of
oxidative stress.Journal of Biomedicine and Biotechnology 9
8. PI3K and Occludin Phosphorylation
PI3K(phosphatidylinositol-3-kinase)signalingisinvolvedin
the regulation of multiple cellular processes including meta-
bolism, proliferation, cell death, and migration. Deregula-
ted activation of PI3K is frequently associated with cancer.
PI3Ks are divided into three classes of proteins. Class I PI3Ks
generate the second messenger phosphatidyl-3,4,5-trisphos-
phate (PIP3) in phosphorylating the lipid phosphatidyl-4,5-
diphosphate. Class I PI3Ks are subdivided into classes IA
and IB, activated by receptor tyrosine kinases (RTKs), or G
protein-coupled receptors (GPCRs), respectively. Class IA
PI3Ks are composed of regulatory subunits (p85α,p 8 5 β,a n d
p55γ) and p110 (α, β, δ) catalytic subunits. Class IB kinases
are characterized by p101 regulatory subunits and p110γ
catalytic subunits. Both, class II and class III PI3Ks use phos-
phatidylinositol (PI) as a substrate and are involved in mem-
brane traﬃcking and mTOR (mammalian target of rapa-
mycin) signaling, respectively, (for review see [94]).
First evidence for a role of PI3K in occludin-dependent
regulation of TJs was given by the observation that a peptide
derived from the occludin coiled-coil domain pulls down the
PI3K regulatory p85 subunit from T84 human adenocarci-
noma cells [53]. Further evidence for involvement of PI3K
was provided by treatment of Caco-2 cells with the PI3K
inhibitor LY294002 under oxidative stress conditions. Tyro-
sinephosphorylationofoccludinandZO-1,redistributionof
both proteins to the intracellular compartment, decrease in
TER, and increased permeability were signiﬁcantly reduced
in the presence of the inhibitor. Oxidative stress-induced
translocation of p85 to junctions increased coprecipitation
of the PI3K regulatory p85 subunit and kinase activity with
occludin. Direct binding to occludin was further conﬁrmed
using recombinant occludin C-terminus which associates
withpuriﬁedp85subunit[59].Theseobservationssuggested
that PI3K activity is involved in dissociation of TJs. Contrary
observations were reported for dexamethasone-treated Con8
rat mammary epithelial cells where PI3K activity contributes
to TER increase [95]. Recently it has been reported that PI3K
in addition to its lipd kinase activity also has protein kinase
activity [96]. It is currently not clear, if amino acid residue/s
in occludin can be directly phosphorylated by PI3K and
whether this aﬀects the regulation of TJs.
9. VEGF-InducedPhosphorylation of Occludin
The vascular endothelial growth factor (VEGF) family con-
tains ﬁve structurally related mammalian ligands (VEGFA,
VEGFB, VEGFC, VEGFD, and placenta growth factor PLGF)
and three VEGF receptor tyrosine kinases (for review [97,
98]).Theycriticallyregulatevasculogenesisandangiogenesis
andhaveearlybeenidentiﬁedtoinduceoccludinphosphory-
lation thereby modulating barrier properties [99]. Although
the downstream kinase is not jet identiﬁed, by analyzing
crude membrane fractionations of bovine retinal endothelial
cells (BRECs) +/− VEGF stimulation and by combining
mass spectrometry data analyses with bioinformatics, S490
in occludin was identiﬁed as the downstream phospho-
site. This phosphorylation site was veriﬁed in vivo using a
phospho-speciﬁc antibody. Mutation of serine 490 to aspar-
tate resulted in diminished binding of the occludin C-termi-
naldomaintoZO-1[100].PhosphorylationofS409inocclu-
din strengthens its interaction with the E3 ubiquitin ligase
Itch and induces occludin ubiquitination [101]. As shown
earlier, Itch interacts with the N-terminal domain of occlu-
din,ubiquitinatesoccludinandtargetsittoproteasomaldeg-
radation [102]. VEGF-induced ubiquitination strengthens
the interaction of occludin, with modulators of intracellular
traﬃckingincludingEpsin-1,epidermalgrowthfactorrecep-
tor pathway substrate 15 (Eps15), and hepatocyte growth
factor-regulated tyrosine kinase substrate (Hrs) and induces
its degradation. Administration of VEGF to BRECs induces
the fragmentation of TJs as measured by a decrease in TER
and increased permeability of the tracer 70-kDa-rhodamine
B isothiocyanate dextran. Occludin traﬃcking from the cell
border to early and late endosomes was enhanced, whereas a
S490AmutationsuppressedtheseVEGFeﬀects.Theseobser-
vations for the ﬁrst time linked occludin phosphorylation
with degradation pathways.
10. Phosphatases Counteracting
Occludin Phosphorylation
To achieve the highly coordinated regulation of cellular sig-
nalingpathways,theactionofmostkinaseshastobereverted
by speciﬁc phosphatase reactions. In the context of occludin
phosphorylation, PP2A, PP1 and DEP-1 were identiﬁed as
phosphatases that are able to counteract serine/threonine
and tyrosine kinase activities, respectively. Nevertheless,
much less is known about occludin phosphatases and it is
assumed that further phosphatases able to modulate occlu-
din and TJ function will be identiﬁed.
Protein phosphatase 1 (PP1) and PP2A represent the
major protein Ser/Thr phosphatases in eukaryotic cells. They
are ubiquitously expressed in all eukaryotic organisms with
multiplefunctions(forreviewsee[103]).ThefunctionalPP1
enzyme consists of a highly conserved catalytic subunit asso-
ciated with one out of many regulatory subunits. More than
100 putative regulatory subunits have been identiﬁed, which
deﬁnelocalizationand/orsubstratespeciﬁcityoftheenzyme.
PP2A is composed of a heterodimeric core enzyme, consist-
ing of a scaﬀold subunit (A, PR65) and catalytic subunit
(C), which interacts with variable regulatory subunits (B) to
formtheactivePP2Aholoenzyme.TheBsubunitsdetermine
targetingofPP2Atospeciﬁcintracellulardomainsanddeﬁne
recruitment to distinct signaling complexes. The expression
levels of these regulatory subunits are variable between dif-
ferent tissues and cell types. The receptor-type protein tyro-
sine phosphatase DEP-1 (density-enhanced protein tyrosine
phosphatase-1), also known as CD148, PTP-η,h i g hc e l ld e n -
sity-enhanced PTP (HPTP-η), is a member of the type III
family of protein tyrosine phosphatases (PTPs) and is widely
expressed in many cell types including epithelial and endo-
thelialcells.Atumorsuppressorfunctionwasassociatedwith
DEP-1 in genetic studies, which is supported by known sub-
strates including c-Met (HGFR), p120ctn,c - S r c ,a n dP I 3 K
(for review see [104]).10 Journal of Biomedicine and Biotechnology
Inhibition of PTPs in human umbilical vein endothelial
cells (HUVECs) by phenylarsine oxide or pervanadate in-
duces metalloproteinase-mediated progressive disappear-
ance of occludin from the cell-cell contacts and elevates per-
meability of FITC-dextrans (4.4kDa and 38.26kDa) [105].
FurtherstudiesbyNunbhakdi-Craigetal.[106]revealedthat
the PP2A holoenzyme containing the Bα subunit dissociates
from junctional contacts in response to lowering of Ca2+ in
the medium and redistributes to junctional complexes after
readdition of Ca2+. A recent report has suggested that hypo-
glycosylated E-cadherin enhanced recruitment of PP2A to
adherens junctions. This resulted in diminished binding of
PP2A to ZO-1 and claudin-1, and thus more ZO-1 was
found associated with occludin and claudin-1 correlating
with increased TER [107]. In coimmunoprecipitation exper-
iments with an anti-Bα antibody, occludin, claudin-1, and
ZO-1 formed a complex with PP2A. This observation was
conﬁrmed in vice versa experiments with an anti-occludin
antibody precipitating Bα from rat colon and kidney homo-
genates. The inhibition of PP2A activity with ocadaic acid
(OA) enhanced occludin phosphorylation, accelerated TJ
assembly, and increased TER. Moreover, this study shows
thatoccludin,whichwasprephosphorylatedbyaPKCζ,isde-
phosphorylated by PP2A. Interestingly, PP2A associates with
PKCζ in coimmunoprecipitation experiments and appears
to be involved in the regulation of PKCζ.I nM D C Kc e l l s
overexpressing the catalytic subunit of PP2A, recruitment
of PKCζ to junctional complexes was impaired during TJ
biogenesis [106]. In pulmonary adenocarinoma Calu-3 cells,
Vermeer et al. [108] showed a similar complex formation
between PP2A and occludin, claudin-1 and aPKCλ at the cell
junctions and dissociation of PP2A from occludin and clau-
dins when TJs are disintegrated. Disruption of TJs is a pre-
requisite for apically secreted EGF ligands to activate their
basolateral receptors [109]. Concomitant with an EGF-indu-
ced tyrosine phosphorylation of the PP2A catalytic subunit,
PP2A is inactivated allowing phosphorylation of aPKC and
its translocation to tight junctional complexes thus promo-
ting assembly [106, 108]. Under inﬂammatory conditions,
which were simulated by TNFα/IFNγ treatment, junctional
integrity was compromised leading to a drop in TER which
was reverted in the presence of ocadaic acid [108]. Thus,
accessibility of Erb receptors for their ligands, leading to
PP2A inactivation, allows rapid restoration of barrier integ-
rity essential to protect the epithelium from environmental
insults.
Treatment of Caco-2 cells with EGTA to induce opening
of TJs increases the direct association of the occludin C-ter-
minal domain with the catalytic subunit of PP2A and of
PP1 and vice versa, whereas readdition of Ca2+ gradually
reduced this interaction. Knockdown of PP2A or PP1 acce-
lerates TJ assembly, recovery of TER, and barrier function.
Interestingly, in in vitro phosphatase assays, PP2A dephos-
phorylates the occludin C-terminus on phospho-threonine
residues, whereas PP1α dephosphorylates it on phospho-
serine residues [110]. However, the in vivo roles of occludin
serine phosphorylation and PP1 currently are not clear. It
was speculated that serine phosphorylation of occludin may
stabilize TJs once they are assembled, or that PP1 associates
with occludin to target other components of the TJ complex
[110]. Consistent with the previous ﬁndings, H2O2-induced
disassembly of TJs was associated with PP2A-mediated de-
phosphorylation of occludin. Interestingly, tyrosine phos-
phorylation of GST-occludin C-terminus enhanced PP2A
binding.
The important role of serine/threonine phosphatases for
the TJ barrier properties was emphasized by the ﬁnding that
enteropathogenic E. coli-induced disruption of TJs was bloc-
ked by calyculin A [111].
Using a catalytically dead substrate-trapping mutant, the
receptor tyrosine phosphatase DEP-1 has been shown to
interact with occludin in a tyrosine phosphorylation-depen-
dent manner in MCF10A and MDCK II cells, whereas PTP-
PEST, Shp2, or PTPμ did not bind. Overexpression of DEP-1
enhances barrier function during TJ reassembly whereas
a knockdown of DEP-1 increased epithelial permeability
[112].
11. Conclusions
Multiple kinases targeting occludin and thereby modulating
TJ assembly, structure, and function have been characterized
and speciﬁc serine, threonine, and tyrosine residues targeted
by these kinases have been identiﬁed (for summary see
Table 1). Currently, it is well accepted that tyrosine phos-
phorylation destabilizes TJs whereas especially threonine
phosphorylation by atypical PKCs promotes TJ assembly. In
addition to those kinases discussed here in more detail, fur-
ther kinases have been suggested to be involved in the modu-
lation of TJ function including p34cdc2/cyclinB [90], ATM/
ATR [113], AMPK, and GSK3β [114]. However, direct bind-
ing and phosphorylation sites have to be deﬁned for most
of them. Dynamic phosphorylation of occludin appears to
play an important role in the assembly/disassembly of TJs.
Thus, phosphorylation and dephosphorylation of occludin
has to be exactly balanced. Whether and how sequential
actions of kinases are involved in these processes is currently
not clear. Depending on the stimulus, the sequence of phos-
phorylationsorthetargetedaminoacidresiduesmaychange.
It is noteworthy that within the occludin C-terminal domain
a hotspot for phosphorylation events exists between Y398-
S408 that is used by PKCη and ζ, Src kinase and CK2 (see
Figure 1). It is likely that the cooperation of multiple kinases
within this stretch of 10 amino acids modulates the charge
distribution in occludin thereby regulating occludin func-
tion.
The generation of further phospho-site-speciﬁc antibod-
ieswillbeahelpfultoolforfutureinvestigationsinthisdirec-
tion. Recent studies clearly have indicated that the mobility
of TJ components and protein-protein interactions within
the TJ complex are diﬀerentially regulated [18, 92]. Whether
the mobility of these components and in consequence their
interaction is speciﬁcally regulated by the diﬀerent kinases
has to be investigated. Currently, most studies focused on the
phosphorylation of the occludin C-terminal domain. How-
ever, little is known about the N-terminus in this respect.
Experiments showing that the occludin N-terminus is phos-
phorylated in vitro, [87] suggest that this may also occur inJournal of Biomedicine and Biotechnology 11
vivo, for example, in the regulation of Itch-dependent occlu-
din ubiquitination and degradation. Probably, also new con-
text-speciﬁc phosphatases counter-acting kinase activities
willbeidentiﬁed.Ifthesekinasesandphosphatasesareuseful
targets for therapeutic treatment of diseases such as inﬂam-
matory gastrointestinal or pulmonary diseases, or whether
they can be applied to target the blood-brain barrier, are
open questions for intriguing investigations in the future.
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